Literature DB >> 3611949

Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin.

F L Weber, J G Banwell, K M Fresard, J H Cummings.   

Abstract

To determine how lactulose and lactulose plus neomycin might alter nitrogen metabolism in the colon we investigated the effect of these agents on the distribution of nitrogen in the bacterial, soluble, and fiber fractions of stool. The alterations in fecal nitrogen excretion were additionally correlated with changes in total body urea synthesis and degradation rates. Six patients with stable cirrhosis received a control diet alone followed by the administration of lactulose (56 +/- 6 gm/day), and eight similar patients received lactulose alone (63 +/- 5 gm/day) followed by the addition of neomycin (4 gm/day). Their feces were partitioned into individual fractions by physical separation. Lactulose administration increased nitrogen excreted in the bacterial fraction by 165% (from 0.52 +/- 0.14 gm/day to 1.38 +/- 0.21 gm/day) and by 135% in the soluble fraction (from 0.58 +/- 0.08 gm/day to 1.36 +/- 0.23 gm/day). When lactulose was supplemented with neomycin, the nitrogen content of the bacterial fraction decreased by 28%. Lactulose caused a 23% reduction in the urea production rate that was mainly accounted for by increase in fecal nitrogen excretion. The addition of neomycin caused a further reduction in urea production that was explained by an inhibition of urea degradation. These results demonstrate that a major effect of lactulose was to augment the incorporation of nitrogen into fecal bacteria although nitrogen in the soluble fraction also increased. The additional nitrogen excreted in the fecal bacterial and soluble fractions caused a reduction in urea synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611949

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  11 in total

1.  Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy.

Authors:  S P Bird; D Hewitt; B Ratcliffe; M I Gurr
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

Review 2.  Functional analysis of colonic bacterial metabolism: relevant to health?

Authors:  Henrike M Hamer; Vicky De Preter; Karen Windey; Kristin Verbeke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-20       Impact factor: 4.052

3.  Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.

Authors:  K Tarao; T Ikeda; K Hayashi; A Sakurai; T Okada; T Ito; H Karube; T Nomoto; T Mizuno; K Shindo
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

Review 4.  Lactulose, disaccharides and colonic flora. Clinical consequences.

Authors:  M R Clausen; P B Mortensen
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 5.  Hyperammonemia in Inherited Metabolic Diseases.

Authors:  Graziela Schmitt Ribas; Franciele Fátima Lopes; Marion Deon; Carmen Regla Vargas
Journal:  Cell Mol Neurobiol       Date:  2021-10-19       Impact factor: 4.231

Review 6.  Hepatic disorders. Features and appropriate management.

Authors:  M A Aldersley; J G O'Grady
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 7.  The why and wherefore of hepatic encephalopathy.

Authors:  Vijay Pb Grover; Joshua M Tognarelli; Nicolas Massie; Mary Me Crossey; Nicola A Cook; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2015-12-16

Review 8.  Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.

Authors:  Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2016-09-16       Impact factor: 3.584

Review 9.  Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.

Authors:  Daniela Campion; Ilaria Giovo; Paola Ponzo; Giorgio M Saracco; Federico Balzola; Carlo Alessandria
Journal:  World J Hepatol       Date:  2019-06-27

Review 10.  Use Of Quantitative Modelling To Elucidate The Roles Of The Liver, Gut, Kidney, And Muscle In Ammonia Homeostasis And How Lactulose And Rifaximin Alter This Homeostasis.

Authors:  Michael D Levitt; David G Levitt
Journal:  Int J Gen Med       Date:  2019-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.